Current strategies for tracheal replacement: a review

G Damiano, VD Palumbo, S Fazzotta, F Curione… - Life, 2021 - mdpi.com
Airway cancers have been increasing in recent years. Tracheal resection is commonly
performed during surgery and is burdened from post-operative complications severely …

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes

D Chiu, J Rhee, LN Gonzalez Castro - Antibodies, 2023 - mdpi.com
Paraneoplastic antibody syndromes result from the anti-tumor antibody response against
normal antigens ectopically expressed by tumor cells. Although this antibody response plays …

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma

Y Katsuya, Y Fujita, H Horinouchi, Y Ohe, S Watanabe… - Lung Cancer, 2015 - Elsevier
Purpose The immune checkpoint ligand programmed cell death 1 ligand 1 (PD-L1) is
expressed in various tumors and is associated with the response to anti programmed cell …

Thymoma: a clinicopathological correlation of 1470 cases

A Weissferdt, N Kalhor, JA Bishop, SJ Jang, J Ro… - Human pathology, 2018 - Elsevier
We present 1470 surgical resections for thymoma identified in the pathology files of 14
institutions from 11 countries with the purpose of determining and correlating a simplified …

[HTML][HTML] Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic …

AC Roden, SY Eunhee, SM Jenkins… - Journal of Thoracic …, 2015 - Elsevier
Introduction The prognostic value of histopathologic classifications of thymoma is debated.
Problematic reproducibility might cause this controversy. We studied the prognostic …

Thymic Imaging Pitfalls and Strategies for Optimized Diagnosis

M Klug, CD Strange, MT Truong, Z Kirshenboim… - …, 2024 - pubs.rsna.org
Thymic imaging is challenging because the imaging appearance of a variety of benign and
malignant thymic conditions are similar. CT is the most commonly used modality for …

Clinicopathologic and prognostic implications of programmed death ligand 1 expression in thymoma

S Yokoyama, H Miyoshi, T Nishi, T Hashiguchi… - The Annals of thoracic …, 2016 - Elsevier
Background Programmed death ligand 1 (PD-L1) has been reported to be expressed in
various malignancies and is considered to be a prognostic factor and an immunotherapeutic …

[HTML][HTML] Too early to be different? A multi-institutional study with 30-year follow-up for prognostic factors of completely resected early stage thymoma

EK Tang, YF Wei, CC Chang, WM Wang, CY Wu… - Journal of the Formosan …, 2024 - Elsevier
Abstract Background/Purpose This multi-institutional study was aimed to analyze prognostic
factors of completely resected early stage thymoma. Methods Patients with surgically treated …

Paraneoplastic and therapy-related immune complications in thymic malignancies

EA Lippner, DB Lewis, WH Robinson… - Current treatment options …, 2019 - Springer
Opinion statement The thymus is a key organ involved in establishing central immune
tolerance. Thymic epithelial tumors (TETs) include thymomas and thymic carcinomas …

The clinical features, diagnosis and management of recurrent thymoma

T Luo, H Zhao, X Zhou - Journal of Cardiothoracic Surgery, 2016 - Springer
Thymoma is a disease with malignant potential, which has a recurrence rate after complete
resection ranging from 5 to 50%. Multiple studies on the risk factors, treatment or prognosis …